Nanodelivery of Cerebrolysin and Rearing in Enriched Environment Induce Neuroprotective Effects in a Preclinical Rat Model of Parkinson’s Disease

被引:0
|
作者
C. Requejo
J. A. Ruiz-Ortega
H. Cepeda
A. Sharma
H. S. Sharma
A. Ozkizilcik
R. Tian
H. Moessler
L. Ugedo
J. V. Lafuente
机构
[1] University of the Basque Country (UPV/EHU),LaNCE, Department of Neuroscience
[2] University of the Basque Country (UPV/EHU),Department of Pharmacology
[3] Uppsala University,International Experimental CNS Injury & Repair
[4] Uppsala University Hospital,Department of Surgical Sciences, Anesthesiology & Intensive Care Medicine
[5] Uppsala University,Department of Biomedical Engineering
[6] University of Arkansas,Department of Chemistry & Biochemistry
[7] University of Arkansas,Drug Discovery & Develop
[8] Ever Neuro Pharma,Nanoneurosurgery Group
[9] BioCruces Health Research Institute,Faculty of Health Science
[10] Universidad Autónoma de Chile,undefined
来源
Molecular Neurobiology | 2018年 / 55卷
关键词
Parkinson’s disease; 6-OHDA; Preclinical stage; Nanowired cerebrolysin; Enriched environment; Neuroprotection;
D O I
暂无
中图分类号
学科分类号
摘要
Rearing in enriched environment (EE) improves the recuperation in animal models of Parkinson’s disease (PD). Administration of TiO2-nanowired cerebrolysin (CBL) could represent an additional strategy to protect or repair the nigrostriatal system. This study aims to explore morphofunctional and biochemical changes in a preclinical stage of PD testing the synergistic efficiency of combining both strategies, housing in EE, and nanodelivery of CBL. Sprague-Dawley male rats receiving intrastriatally 6-hydroxydopamine after a short evolution time were segregated into CBL group (rats receiving nanowired CBL), EE group (rats housed in EE), CBL + EE group (rats housed in EE and receiving nanowired CBL), and control group (rats without additional treatment). Prodromic stage and treatment effects were characterized by the presence of motor symptoms (amphetamine-induced rotational behavior test). Tyrosine hydroxylase (TH) immunohistochemistry and Western blot (p-Akt/Akt and p-ERK/ERK 1/2 as survival markers and caspase-3 as apoptotic marker) were performed in striatum and SN. A decrease in motor symptoms was shown by rats receiving CBL. EE monitoring cages revealed that rats from CBL + EE group showed more significant number of laps in the wheel than EE group. In SN, CBL + EE group also presented the highest neuronal density. Moreover, p-Akt/Akt and p-ERK/ERK 1/2 ratio was significant higher and caspase-3 expression was lower in CBL + EE group. In conclusion, the combination of CBL and EE provided evidence of neuoprotective-neurorestorative mechanisms by which this combined strategy promoted morphofunctional improvement by activation of survival pathways after dopamine depletion in a preclinical model of PD.
引用
收藏
页码:286 / 299
页数:13
相关论文
共 50 条
  • [21] Neuroprotective and neurorestorative effects of training on dopaminergic transplants in a rat lesion model of Parkinson's disease
    Kloth, V
    Klein, A
    Lottrich, D
    Schmidt, MB
    Hackl, C
    Nikkhah, G
    CELL TRANSPLANTATION, 2003, 12 (03) : 309 - 310
  • [22] Neuroprotective effects of coadministration of HB-GAM and GDNF in a rat model of Parkinson's disease
    Piltonen, Marjo
    Ervasti, Dagmar
    Rauvala, Heikki
    Saarma, Mart
    Mannisto, Pekka T.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 34 (01) : S9 - S9
  • [23] Neuroprotective effects of a single injection of GDNF in a rat model of early Parkinson's disease.
    Cass, WA
    Peters, LE
    Smith, MP
    EXPERIMENTAL NEUROLOGY, 2004, 187 (01) : 205 - 205
  • [24] Neuroprotective Effects of Paeoniflorin on 6-OHDA-Lesioned Rat Model of Parkinson’s Disease
    Xiao-Su Gu
    Fen Wang
    Cai-Yi Zhang
    Cheng-Jie Mao
    Jing Yang
    Ya-Ping Yang
    Sha Liu
    Li-Fang Hu
    Chun-Feng Liu
    Neurochemical Research, 2016, 41 : 2923 - 2936
  • [25] Neuroprotective Effects of Paeoniflorin on 6-OHDA-Lesioned Rat Model of Parkinson's Disease
    Gu, Xiao-Su
    Wang, Fen
    Zhang, Cai-Yi
    Mao, Cheng-Jie
    Yang, Jing
    Yang, Ya-Ping
    Liu, Sha
    Hu, Li-Fang
    Liu, Chun-Feng
    NEUROCHEMICAL RESEARCH, 2016, 41 (11) : 2923 - 2936
  • [26] Neuroprotective effects of voluntary running on cognitive dysfunction in an α-synuclein rat model of Parkinson's disease
    Crowley, Erin K.
    Nolan, Yvonne M.
    Sullivan, Aideen M.
    NEUROBIOLOGY OF AGING, 2018, 65 : 60 - 68
  • [27] Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease
    Datla, KP
    Christidou, M
    Widmer, WW
    Rooprai, HK
    Dexter, DT
    NEUROREPORT, 2001, 12 (17) : 3871 - 3875
  • [28] Chronic antidepressant treatment is neuroprotective in a rat model of Parkinson's disease
    Paumier, K. L.
    Sortwell, C. E.
    Daley, B. F.
    Terpstra, B. T.
    Levine, N. D.
    Madhaven, L. M.
    Collier, T. J.
    MOVEMENT DISORDERS, 2008, 23 (01) : S316 - S317
  • [29] The neuroprotective effects of Cerebrolysin™ in a transgenic model of Alzheimer’s disease are associated with improved behavioral performance
    E. Rockenstein
    A. Adame
    M. Mante
    H. Moessler
    M. Windisch
    E. Masliah
    Journal of Neural Transmission, 2003, 110 : 1313 - 1327
  • [30] Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models
    Hu, Li-Fang
    Lu, Ming
    Tiong, Chi Xin
    Dawe, Gavin S.
    Hu, Gang
    Bian, Jin-Song
    AGING CELL, 2010, 9 (02): : 135 - 146